A system for predicting the degree of liver fibrosis in patients with chronic hepatitis B virus infection with normal or mildly elevated alanine aminotransferase

A hepatitis B virus, chronic hepatitis B technology, applied in the system field of predicting the degree of liver fibrosis in chronic hepatitis B virus-infected patients with normal or slightly elevated alanine aminotransferase

Active Publication Date: 2017-02-01
PEKING UNIV FIRST HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Existing studies on non-invasive fibrosis diagnostic indicators or models of chronic hepatitis B are mainly limited to the cohort with elevated ALT (especially ALT≥2ULN), and few people with normal or mildly elevated ALT (ALT<2ULN) concerned

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A system for predicting the degree of liver fibrosis in patients with chronic hepatitis B virus infection with normal or mildly elevated alanine aminotransferase
  • A system for predicting the degree of liver fibrosis in patients with chronic hepatitis B virus infection with normal or mildly elevated alanine aminotransferase
  • A system for predicting the degree of liver fibrosis in patients with chronic hepatitis B virus infection with normal or mildly elevated alanine aminotransferase

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1. Non-invasive model Fib-index is used to predict the degree of liver fibrosis in patients with chronic hepatitis B virus infection with normal or slightly elevated alanine aminotransferase

[0042] 1. Establishment of non-invasive model Fib-index

[0043] 1. Research object

[0044] (1) Case source: chronic hepatitis B virus infection patients from 24 centers across the country in October 2013 and September 2014. (2) Inclusion criteria: age 18-65 years old; HBsAg positive history for half a year or more. (3) Exclusion criteria: patients with chronic hepatitis C, AIDS infection, hereditary liver disease, drug liver, non-alcoholic fatty liver and other basic patients, patients with primary liver cancer, liver cirrhosis, and pregnant women. All patients signed the informed consent before enrollment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to view more

Abstract

The invention discloses a system for predicting a chronic hepatitis B virus infected patient liver fibrosis degree with normal or slightly increased glutamic-pyruvic transaminase. A non-invasive model Fib-index established by adopting a transforming growth factor-alpha, an interleukin-2 receptor, thrombocyte, hepatitis B antigen e and hepatitis B virus DNA as markers has diagnosis value for a chronic hepatitis B virus infected patient with ALT normal or slightly increased (less than 2ULN) and ALT greater than or equal to 2LN. The non-invasive model Fib-index can predict the liver fibrosis degree of the chronic hepatitis B virus infected patient according to the level of a cycling cell factor, is a non-invasive detection method and is expected to assist a clinical treatment decision.

Description

technical field [0001] The invention relates to a system for predicting the degree of liver fibrosis in patients with chronic hepatitis B virus infection with normal or slightly elevated alanine aminotransferase in the field of biomedicine. Background technique [0002] Alanine aminotransferase (ALT) has been widely used clinically as an important indicator for screening and monitoring liver diseases for a long time. The Asia-Pacific and American Society of Liver Diseases guidelines on chronic hepatitis B all regard the increase of ALT value more than 2 times ULN (upper limit of normal, upper limit of normal value) as one of the necessary conditions for antiviral treatment for patients with chronic hepatitis B virus infection . However, the literature shows that patients with chronic hepatitis B virus infection with normal or slightly elevated ALT (<2ULN) may also have hidden damage to the liver. If antiviral treatment is not given immediately, the disease may be delayed...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/576G01N33/68C12Q1/06C12Q1/70C12Q1/68C12R1/93
CPCC12Q1/06G01N33/5761G01N33/6869G01N33/6872
Inventor 王贵强邓永琼赵鸿李俊王艳洪源周继远
Owner PEKING UNIV FIRST HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products